<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6716213/results/search/drugs/results.xml">
  <result pre="on pharmacological treatment of headache in the pediatric population. Only" exact="ibuprofen" post="and sumatriptan are significantly more effective than placebo in"/>
  <result pre="treatment of headache in the pediatric population. Only ibuprofen and" exact="sumatriptan" post="are significantly more effective than placebo in determining headache"/>
  <result pre="mg sumatriptan/60 mg naproxen, max dose 85 mg sumatriptan/500 mg" exact="naproxen" post="IN, Intranasal; Max, Maximum; ODT, Orally disintegrating tablet; PO,"/>
  <result pre="kg: 4–8 mg Sedation Dystonic reaction Oral analgesics such as" exact="paracetamol" post="(10–15 mg per kg) and ibuprofen (10 mg per"/>
  <result pre="Oral analgesics such as paracetamol (10–15 mg per kg) and" exact="ibuprofen" post="(10 mg per kg) are the mainstay of acute"/>
  <result pre="Administration for acute migraine in adolescents 12–17 years of age:" exact="almotriptan" post="(oral), zolmitriptan (nasal spray), rizatriptan (oral), and sumatriptan/naproxen (oral);"/>
  <result pre="acute migraine in adolescents 12–17 years of age: almotriptan (oral)," exact="zolmitriptan" post="(nasal spray), rizatriptan (oral), and sumatriptan/naproxen (oral); and one"/>
  <result pre="adolescents 12–17 years of age: almotriptan (oral), zolmitriptan (nasal spray)," exact="rizatriptan" post="(oral), and sumatriptan/naproxen (oral); and one medication, rizatriptan (melt),"/>
  <result pre="(nasal spray), rizatriptan (oral), and sumatriptan/naproxen (oral); and one medication," exact="rizatriptan" post="(melt), is labeled for use in children 6 years"/>
  <result pre="h after acute headache treatment. Based on a systematic review," exact="ibuprofen" post="seems more effective, making it an excellent choice for"/>
  <result pre="it an excellent choice for the treatment of head pain;" exact="paracetamol" post="has not been shown to be effective in providing"/>
  <result pre="relief. In a small cross-over study, predominantly in children, oral" exact="paracetamol" post="was not superior to placebo or ibuprofen ( 88)."/>
  <result pre="in children, oral paracetamol was not superior to placebo or" exact="ibuprofen" post="( 88). Triptans were more effective than placebo in"/>
  <result pre="nasal symptoms, and nausea with intranasal preparations. The combination of" exact="sumatriptan" post="with naproxen sodium was also more effective than placebo"/>
  <result pre="and nausea with intranasal preparations. The combination of sumatriptan with" exact="naproxen" post="sodium was also more effective than placebo in producing"/>
  <result pre="Acute treatment of head pain via saline infusion, with intravenous" exact="ketorolac" post="(0.5 mg/kg with a maximum dose of 30 mg)"/>
  <result pre="(0.5 mg/kg with a maximum dose of 30 mg) and" exact="prochlorperazine" post="(0.15 mg/kg with a maximum dose of 10 mg),"/>
  <result pre="recent study comparing the effectiveness of three commonly used parenteral" exact="dopamine" post="antagonists (prochlorperazine, metoclopramide, and promethazine) to abort pediatric migraine,"/>
  <result pre="(prochlorperazine, metoclopramide, and promethazine) to abort pediatric migraine, found that" exact="promethazine" post="was significantly associated with higher odds of treatment failure"/>
  <result pre="opioid administration and poor pain control. The authors recommend using" exact="prochlorperazine" post="or metoclopramide instead of promethazine for pediatric ED migraine"/>
  <result pre="and poor pain control. The authors recommend using prochlorperazine or" exact="metoclopramide" post="instead of promethazine for pediatric ED migraine treatment ("/>
  <result pre="control. The authors recommend using prochlorperazine or metoclopramide instead of" exact="promethazine" post="for pediatric ED migraine treatment ( 91). Dihydroergotamine (DHE)"/>
  <result pre="studies were weakened by prior treatment of the subjects with" exact="dopamine" post="agonists. A recent study on treatment of 145 patients"/>
  <result pre="while recurrence of headache after ED discharge was 33%. Sodium" exact="valproate" post="IV could represent a treatment option for acute migraine,"/>
  <result pre="ML Hoppu K Valkeila E Santavuori P . Ibuprofen or" exact="acetaminophen" post="for the acute treatment of migraine in children: a"/>
  <result pre="Treatment of pediatric migraine headaches: a randomized, double-blind trial of" exact="prochlorperazine" post="versus ketorolac . Ann Emerg Med. ( 2004) 43:"/>
  <result pre="pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus" exact="ketorolac" post=". Ann Emerg Med. ( 2004) 43: 256– 62."/>
  <result pre="Hansen ML Ma OJ et al. . Relative effectiveness of" exact="dopamine" post="antagonists for pediatric migraine in the emergency department ."/>
  <result pre="30234648 93. Linder SL . Treatment of childhood headache with" exact="dihydroergotamine" post="mesylate. Headache. ( 1994) 34: 578– 80. 7843951 94."/>
  <result pre="S et al. . Inpatient treatment of status migraine with" exact="dihydroergotamine" post="in children and adolescents. Headache. ( 2009) 49: 106–"/>
  <result pre="19125879 95. Hämäläinen ML Hoppu K Santavuori PR . Oral" exact="dihydroergotamine" post="for therapy-resistant migraine attacks in children. Pediatr Neurol. ("/>
  <result pre="LM . Outcome and cost of inpatient hospitalization for intravenous" exact="dihydroergotamine" post="treatment of refractory pediatric headache . Pediatr eurol. ("/>
  <result pre="Nickisch J Merritt G . Efficacy and tolerability of intravenous" exact="valproic acid" post="in acute adolescent migraine. Headache. ( 2005) 45: 899–"/>
  <result pre="D Sun B O'Brien P Hansen M . Intravenous sodium" exact="valproate" post="for acute pediatric headache. J Emerg Med. ( 2015)"/>
 </snippets>
</snippetsTree>
